276 related articles for article (PubMed ID: 35205279)
1. Role of the Mediator Complex and MicroRNAs in Breast Cancer Etiology.
Maldonado E; Morales-Pison S; Urbina F; Jara L; Solari A
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205279
[TBL] [Abstract][Full Text] [Related]
2. Arginine and glutamate-rich 1 (ARGLU1) interacts with mediator subunit 1 (MED1) and is required for estrogen receptor-mediated gene transcription and breast cancer cell growth.
Zhang D; Jiang P; Xu Q; Zhang X
J Biol Chem; 2011 May; 286(20):17746-54. PubMed ID: 21454576
[TBL] [Abstract][Full Text] [Related]
3. MED1/TRAP220 exists predominantly in a TRAP/ Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription.
Zhang X; Krutchinsky A; Fukuda A; Chen W; Yamamura S; Chait BT; Roeder RG
Mol Cell; 2005 Jul; 19(1):89-100. PubMed ID: 15989967
[TBL] [Abstract][Full Text] [Related]
4. Essential role of MED1 in the transcriptional regulation of ER-dependent oncogenic miRNAs in breast cancer.
Nagpal N; Sharma S; Maji S; Durante G; Ferracin M; Thakur JK; Kulshreshtha R
Sci Rep; 2018 Aug; 8(1):11805. PubMed ID: 30087366
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor coactivator Mediator Subunit 1 (MED1) as a tissue-specific therapeutic target in breast cancer.
Leonard M; Zhang X
J Zhejiang Univ Sci B; 2019 May; 20(5):381-390. PubMed ID: 31090264
[TBL] [Abstract][Full Text] [Related]
6.
Immarigeon C; Bernat-Fabre S; Augé B; Faucher C; Gobert V; Haenlin M; Waltzer L; Payet A; Cribbs DL; Bourbon HG; Boube M
Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670567
[TBL] [Abstract][Full Text] [Related]
7. Silencing MED1 sensitizes breast cancer cells to pure anti-estrogen fulvestrant in vitro and in vivo.
Zhang L; Cui J; Leonard M; Nephew K; Li Y; Zhang X
PLoS One; 2013; 8(7):e70641. PubMed ID: 23936234
[TBL] [Abstract][Full Text] [Related]
8. MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor.
Chen W; Rogatsky I; Garabedian MJ
Mol Endocrinol; 2006 Mar; 20(3):560-72. PubMed ID: 16239257
[TBL] [Abstract][Full Text] [Related]
9. The transcriptional coactivator DRIP/mediator complex is involved in vitamin D receptor function and regulates keratinocyte proliferation and differentiation.
Oda Y; Chalkley RJ; Burlingame AL; Bikle DD
J Invest Dermatol; 2010 Oct; 130(10):2377-88. PubMed ID: 20520624
[TBL] [Abstract][Full Text] [Related]
10. Mediator complex subunit Med19 binds directly GATA transcription factors and is required with Med1 for GATA-driven gene regulation
Immarigeon C; Bernat-Fabre S; Guillou E; Verger A; Prince E; Benmedjahed MA; Payet A; Couralet M; Monte D; Villeret V; Bourbon HM; Boube M
J Biol Chem; 2020 Sep; 295(39):13617-13629. PubMed ID: 32737196
[TBL] [Abstract][Full Text] [Related]
11. HER2-Driven Breast Tumorigenesis Relies upon Interactions of the Estrogen Receptor with Coactivator MED1.
Yang Y; Leonard M; Zhang Y; Zhao D; Mahmoud C; Khan S; Wang J; Lower EE; Zhang X
Cancer Res; 2018 Jan; 78(2):422-435. PubMed ID: 29187405
[TBL] [Abstract][Full Text] [Related]
12. Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.
Lee YL; Ito K; Pi WC; Lin IH; Chu CS; Malik S; Cheng IH; Chen WY; Roeder RG
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33542097
[TBL] [Abstract][Full Text] [Related]
13. Inferring coregulation of transcription factors and microRNAs in breast cancer.
Wu JH; Sun YJ; Hsieh PH; Shieh GS
Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Med1 deletion promotes early lethality, cardiac remodeling, and transcriptional reprogramming.
Spitler KM; Ponce JM; Oudit GY; Hall DD; Grueter CE
Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H768-H780. PubMed ID: 28159809
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional coactivator MED1 in the interface of anti-estrogen and anti-HER2 therapeutic resistance.
Bick G; Zhang J; Lower EE; Zhang X
Cancer Drug Resist; 2022; 5(2):498-510. PubMed ID: 35800368
[TBL] [Abstract][Full Text] [Related]
16. Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.
Maillot G; Lacroix-Triki M; Pierredon S; Gratadou L; Schmidt S; Bénès V; Roché H; Dalenc F; Auboeuf D; Millevoi S; Vagner S
Cancer Res; 2009 Nov; 69(21):8332-40. PubMed ID: 19826037
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
[TBL] [Abstract][Full Text] [Related]
18. Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.
Joseph C; Macnamara O; Craze M; Russell R; Provenzano E; Nolan CC; Diez-Rodriguez M; Sonbul SN; Aleskandarany MA; Green AR; Rakha EA; Ellis IO; Mukherjee A
Br J Cancer; 2018 Apr; 118(8):1142-1151. PubMed ID: 29588513
[TBL] [Abstract][Full Text] [Related]
19. Association of miR-1266 with recurrence/metastasis potential in estrogen receptor positive breast cancer patients.
Sevinc ED; Egeli U; Cecener G; Tezcan G; Tunca B; Gokgoz S; Tasdelen I; Tolunay S; Evrensel T
Asian Pac J Cancer Prev; 2015; 16(1):291-7. PubMed ID: 25640367
[TBL] [Abstract][Full Text] [Related]
20. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
